| scholarly article | Q13442814 |
| P50 | author | James R Johnson | Q89498724 |
| Jacob Strahilevitz | Q104980952 | ||
| Ari Robicsek | Q104982006 | ||
| P2093 | author name string | Lance R Peterson | |
| Hongyan Du | |||
| Ritu Banerjee | |||
| Donna M Schora | |||
| Ilene Shevrin | |||
| Payal P Nagwekar | |||
| P2860 | cites work | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 |
| Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases | Q46956002 | ||
| Variation in the genetic environments of bla(CTX-M-15) in Escherichia coli from the faeces of travellers returning to the United Kingdom | Q47591521 | ||
| Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. | Q51816409 | ||
| Identification of extended-spectrum β-lactamase and quinolone resistance genes in Escherichia coli isolated from hospital wastewater from central India. | Q54327876 | ||
| Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. | Q54475453 | ||
| No NDM-1 carriage in healthy persons from Mumbai: reassuring for now | Q83221500 | ||
| Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 | ||
| CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents | Q30407533 | ||
| Dogs of nomadic pastoralists in northern Kenya are reservoirs of plasmid-mediated cephalosporin- and quinolone-resistant Escherichia coli, including pandemic clone B2-O25-ST131. | Q30415484 | ||
| Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers | Q34108669 | ||
| Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy | Q34150900 | ||
| Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk | Q34187502 | ||
| National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases | Q34309458 | ||
| Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City | Q34428189 | ||
| The changing epidemiology of resistance | Q34997021 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains | Q35689050 | ||
| The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance | Q36112353 | ||
| Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community | Q36139832 | ||
| Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States | Q36584908 | ||
| Data analytic methods for matched case-control studies | Q36610352 | ||
| CTX-M: changing the face of ESBLs in Europe | Q36678524 | ||
| European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis | Q36845365 | ||
| Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region | Q37204201 | ||
| Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 | Q37247793 | ||
| Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. | Q37671098 | ||
| Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli | Q38484046 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea | Q39519393 | ||
| Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel | Q39861542 | ||
| High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China | Q41388247 | ||
| Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers | Q42909518 | ||
| Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States | Q43007779 | ||
| Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of Escherichia coli collected from 1991 through 2005. | Q43169864 | ||
| Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. | Q44007887 | ||
| Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients | Q44054169 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes | Q44436393 | ||
| Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children | Q44770831 | ||
| Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand | Q45138244 | ||
| Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. | Q45236129 | ||
| A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. | Q45923958 | ||
| Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 | ||
| P433 | issue | 9 | |
| P921 | main subject | Escherichia coli | Q25419 |
| epidemiology | Q133805 | ||
| P304 | page(s) | 947-953 | |
| P577 | publication date | 2013-07-17 | |
| P1433 | published in | Infection Control and Hospital Epidemiology | Q6029185 |
| P1476 | title | Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community | |
| P478 | volume | 34 |
| Q89517231 | A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children |
| Q27011287 | A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131 |
| Q35607916 | Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice. |
| Q33568677 | Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis |
| Q64106427 | Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population |
| Q53729611 | Characterization of four Escherichia coli clonal groups. |
| Q40525399 | Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae |
| Q57821217 | Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance |
| Q30358381 | Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries. |
| Q40190138 | Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009. |
| Q28073332 | Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis |
| Q34496803 | Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. |
| Q90353826 | Escherichia coli O25b-ST131 and O16-ST131 causing urinary tract infection in women in Changsha, China: molecular epidemiology and clinical characteristics |
| Q34057648 | Escherichia coli ST131, an intriguing clonal group |
| Q37430606 | Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center |
| Q38201515 | Escherichia coli sequence type 131: epidemiology and challenges in treatment. |
| Q37196254 | Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1). |
| Q40171775 | Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains |
| Q40061282 | Guidelines for the prevention of travel-associated illness in older adults |
| Q42872176 | Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. |
| Q37648626 | Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned |
| Q37334691 | Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia |
| Q33732543 | Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children |
| Q34596717 | Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012. |
| Q33806382 | The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012). |
| Q38497797 | The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae |
| Q40196563 | The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world |
| Q90101011 | The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone |
| Q37120219 | Travelers Can Import Colistin-Resistant Enterobacteriaceae, Including Those Possessing the Plasmid-Mediated mcr-1 Gene |
Search more.